Narrow Results By
Consultation on the prescription drug list: Naloxone
https://policybase.cma.ca/link/policy11847
Health Canada’s Consultation on “Plain and Standardized Packaging”
https://policybase.cma.ca/link/policy13817
- Date
- 2016-08-12
- Topics
- Health care and patient safety
- Pharmaceuticals, prescribing, cannabis, drugs
Legalization, regulation and restriction of access to marijuana
https://policybase.cma.ca/link/policy11954
National pharmacare in Canada: Getting there from here
https://policybase.cma.ca/link/policy11959
Policy Brief: CSAM-SMCA in Support of the Decriminalization of Drug Use and Possession for Personal Use
https://policybase.cma.ca/link/policy14443
- Date
- 2021-06-24
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Population health, health equity, public health
- Policy Type
- Policy endorsement
- Date
- 2021-06-24
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Population health, health equity, public health
Documents
Regulation of Self-Care Products in Canada
https://policybase.cma.ca/link/policy13802
- Date
- 2016-10-31
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Health care and patient safety
Regulatory framework for the mandatory reporting of adverse drug reactions and medical device incidents by provincial and territorial healthcare institutions.
https://policybase.cma.ca/link/policy11814
- Date
- 2016-01-20
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Health care and patient safety
Statement to the House of Commons Committee on Health addressing the opioid crisis in Canada
https://policybase.cma.ca/link/policy13936
- Date
- 2016-10-18
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Population health, health equity, public health
- Health care and patient safety
- Policy Type
- Parliamentary submission
- Date
- 2016-10-18
- Topics
- Pharmaceuticals, prescribing, cannabis, drugs
- Population health, health equity, public health
- Health care and patient safety